147 related articles for article (PubMed ID: 27814610)
1. Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease.
Kanatsu K; Tomita T
Front Biosci (Landmark Ed); 2017 Jan; 22(1):180-192. PubMed ID: 27814610
[TBL] [Abstract][Full Text] [Related]
2. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
[TBL] [Abstract][Full Text] [Related]
3. Impact of late-onset Alzheimer's genetic risk factors on beta-amyloid endocytic production.
Guimas Almeida C; Sadat Mirfakhar F; Perdigão C; Burrinha T
Cell Mol Life Sci; 2018 Jul; 75(14):2577-2589. PubMed ID: 29704008
[TBL] [Abstract][Full Text] [Related]
4. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
[TBL] [Abstract][Full Text] [Related]
5. Functional insight into LOAD-associated microglial response genes.
Jonas LA; Jain T; Li YM
Open Biol; 2022 Jan; 12(1):210280. PubMed ID: 35078351
[TBL] [Abstract][Full Text] [Related]
6. From Common to Rare Variants: The Genetic Component of Alzheimer Disease.
Nicolas G; Charbonnier C; Campion D
Hum Hered; 2016; 81(3):129-141. PubMed ID: 28002825
[TBL] [Abstract][Full Text] [Related]
7. Genetics: finding risk factors.
Eisenstein M
Nature; 2011 Jul; 475(7355):S20-2. PubMed ID: 21760580
[No Abstract] [Full Text] [Related]
8. The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.
Wolfe CM; Fitz NF; Nam KN; Lefterov I; Koldamova R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30587772
[TBL] [Abstract][Full Text] [Related]
9. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data.
Campion D; Charbonnier C; Nicolas G
Acta Neuropathol; 2019 Aug; 138(2):173-186. PubMed ID: 30911827
[TBL] [Abstract][Full Text] [Related]
10. New insights into the role of TREM2 in Alzheimer's disease.
Gratuze M; Leyns CEG; Holtzman DM
Mol Neurodegener; 2018 Dec; 13(1):66. PubMed ID: 30572908
[TBL] [Abstract][Full Text] [Related]
11. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
[TBL] [Abstract][Full Text] [Related]
13. Role of TREM2 in Alzheimer's Disease: A Long Road Ahead.
Kulkarni B; Kumar D; Cruz-Martins N; Sellamuthu S
Mol Neurobiol; 2021 Oct; 58(10):5239-5252. PubMed ID: 34275100
[TBL] [Abstract][Full Text] [Related]
14. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
[TBL] [Abstract][Full Text] [Related]
15. Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele.
De Luca V; Spalletta G; Souza RP; Graff A; Bastos-Rodrigues L; Camargos Bicalho MA
Neuropsychobiology; 2019; 77(1):8-12. PubMed ID: 30110694
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.
Patel T; Brookes KJ; Turton J; Chaudhury S; Guetta-Baranes T; Guerreiro R; Bras J; Hernandez D; Singleton A; Francis PT; Hardy J; Morgan K
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):506-521. PubMed ID: 29181857
[TBL] [Abstract][Full Text] [Related]
17. New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.
Misra A; Chakrabarti SS; Gambhir IS
Indian J Med Res; 2018 Aug; 148(2):135-144. PubMed ID: 30381536
[TBL] [Abstract][Full Text] [Related]
18. IPSC-Derived Neuronal Cultures Carrying the Alzheimer's Disease Associated
Martins S; Müller-Schiffmann A; Erichsen L; Bohndorf M; Wruck W; Sleegers K; Van Broeckhoven C; Korth C; Adjaye J
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630447
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
20. APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop.
Murray CE; King A; Troakes C; Hodges A; Lashley T
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):183-186. PubMed ID: 29411406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
